Tag: ent

Optinose Announces Reporting Date for Fourth Quarter and Full Year 2024 Financial Results

YARDLEY, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical…

GlobeNews Wire GlobeNews Wire